Interleukin 10 - A therapeutic cytokine for chronic inflammatory diseases

Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs

Volumn 2, Issue 4, 2000, Pages 307-313

  Narula, S K ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Asthma; Chronic inflammation; COPD; Crohn's disease; Cystic fibrosis; Cytokines; IL 10; Rheumatoid arthritis; T cells

Indexed keywords

ANTIFIBROTIC AGENT; CORTICOSTEROID DERIVATIVE; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 10; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANTIINFLAMMATORY ACTIVITY; ASTHMA; CHRONIC INFLAMMATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CYSTIC FIBROSIS; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG INHIBITION; ENTERITIS; EXPERIMENTAL MODEL; HUMAN; MACROPHAGE; NONHUMAN; REVIEW; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; VIRUS HEPATITIS;

EID: 0033838356     PISSN: 14648474     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (71)

1. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones
2. Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: Homology to Epstein-Barr virus open reading frame BCRFI
3. Homology of cytokine synthesis inhibitor factor (IL-10) to the Epstein-Barr virus gene BCRFI
4. Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin-10
5. Ly-1 B (B-1) cells are the main source of B cell-derived interleukin-10
6. Interleukin-10: A novel stimulatory factor for mast cells and their progenitors
7. II-10 inhibits cytokine synthesis by human monocytes: An autorregulatory role of IL-10 produced by monocytes
8. Identification and induction of keratinocyte-derived IL-10
9. Interleukin 10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells
10. Characterization of interleukin-10 receptors on human and mouse cells
11. A receptor in interleukin-10 is related to interferon receptors
12. Expression cloning and characterization of a human interleukin-10 receptor
13. Identification and function characterization of a second chain of the interleukin-10 receptor complex
14. Stat3 recruitment by two distinct ligand-induced tyrosine phosphorylated docking sites in the IL-10 receptor intracellular domain
15. IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAa and STAT3 complexes in human T cells and monocytes
16. Receptors for interleukin (IL)-10 and il-6 type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements
17. Interleukin-10 stimulation of phosphatidylinositol 3-kinase and p70 S6 kinase is required for the proliferative but not the antiinflammatory effects of the cytokine
18. IL-10 inhibits cytokine production by activated macrophages
19. Functional regions of the mouse IL-10 receptor cytoplasmic domain
20. IL-10 and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II MHC expression
21. Interleukin 10 (IL-10) inhibited the release of proinflammatory cytokines from human polymorphonuclear leukocytes. Evidence for an autocrine role of tumor necrosis factor and IL-in mediating the production of IL-8 triggered by lipopolysaccharide
22. Interleukin-10 is a potent growth and differentiation factor for activated human B cells
23. IL-10 novel cytotoxic T cell differentiation factor
24. J Immunother
25. IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes
26. Macrophage deactivation by interleukin 10
27. Epstein-Barr virus BCRF1 gene product (viral interleukin 10) inhibits superoixide anion production by human monocytes
28. Interleukin-10 deficient mice develop chronic enterocolitis
29. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4+ TH1-like responses
30. Inhibition of Th1 responses prevents inflammatory bowel disease in SCID mice reconstituted with CD45 RB high CD-4+ T cells
31. The cooperative effects of TNF-α and IFN-γ are determining factors in the ability of IL-10 to protect mice from lethal endotoxemia
32. Interleukin 10 protects mice from lethal endotoxemia
33. Pharmacodynamics of subcutaneous recombinant human interleukin-10 in healthy volunteers
34. Pharmacokinetics and leukocyte responses of recombinant human interleukin-10
35. Effects of single intravenous doses of recombinant human interleukin-10 on subsets of circulating leukocytes in humans
36. Attenuation of proinflammatory response by recombinant human IL-10 in human endotoxemia: Effect of timing of recombinant human IL-10 administration
37. Interleukin 10 suppresses experimental chronic granulomatous inflammation induced by bacterial cell wall polymers
38. The effects of interleukin-10 on interleukin-1 receptor antagonist and interleukin-1β production in human monocytes and neutrophils
39. Elevated interleukin-10 levels in patients with rheumatoid arhritis
40. Interleukin-10 (IL-10) secretion in systemic lupus erythematosus and rheumatoid arthritis: IL-10 dependent CD4+-CD45RO+ T cell-B antibody synthesis
41. Balance of IL-1 receptor antagonist/IL-1 β in rheumatoid synovium and its regulation by IL-4 and IL-10
42. Comparison of the suppressive effects of interleukin-10 and interleukin-4 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis
43. Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10
44. Effect of IL-10 on collagen-induced arthritis in mice
45. Interleukin-10 suppresses the development of collagen type II-induced arthritis and ameliorates sustained arthritis in rats
46. Interleukin-10 gene transfer to the airway regulates allergic mucosal sensitization in mice
47. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice
48. IL-10 reduces Th2 cytokine production and eosinophilia but augments airway reactivity in allergic mice
49. Interleukin-10 regulation in normal subjects and patients with asthma
50. Dysregulation of monocyte differentiation in asthmatic subjects is reversed by IL-10
51. Inhaled corticosteroids increase interleukin-10 but reduce macrophage inflammatory protein-1α, granulocyte-macrophage colony-stimulating factor, and interferon-γ release from alveolar macrophages in asthma
52. Haplotype associated with low interleukin-10 production in patients with severe asthma
53. Interleukin-10 and transforming growth factor-β promoter polymorphisms in allergies and asthma
54. Altered respiratory epithelial cell cytokine production in cystic fibrosis
55. Inflammatory cytokines in cystic fibrosis lungs
56. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine IL-10 which is down-regulated in cystic fibrosis
57. IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice
58. Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: A pilot trial of interferon non-responders
59. Interleukin-10 level in sputum is reduced in bronchial asthma, COPD and in smokers
60. Interleukin-8: An important chemoattractant in sputum of subjects with chronic inflammatory airway diseases
61. Interleukin-10 inhibits interleukin-8 production in human neutrophils
62. Interleukin-10 suppresses IL-8 secretion by bronchial epithelial cells
63. Interleukin-10 inhibits allogeneic proliferative and cytotoxic T cell responses generated in primary mixed lymphocyte cultures
64. Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells
65. A CD4 T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
66. Inhibitory and stimulatory effects of IL-10 on human CD8+ T cells
67. Induction of CD4+ T cell alloantigen-specific hyporesponsiveness by IL-10 and TGF-β
68. High levels of IL-10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells
69. Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow
70. Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis